BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
DTSTART:20240331T030000
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20231029T020000
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260424T143500Z
UID:1701077400@ist.ac.at
DTSTART:20231127T103000
DTEND:20231127T113000
DESCRIPTION:Speaker: Leoni Abendstein\nhosted by Martin Loose\nAbstract: In
  our research\, we focused on understanding the activation of the classica
 l complement pathway and the unique features of IgG3 antibodies. The class
 ical complement pathway is initiated by antigen-bound IgG antibodies\, whi
 ch oligomerize to activate complement through the hexameric C1q complex. S
 urprisingly\, structural data has revealed that it is not essential to eng
 age all six arms of C1q to initiate complement activation. This highlights
  a symmetry mismatch between C1 and the hexameric IgG complex\, which rema
 ins unexplained.To address these questions\, we use DNA nanotechnology to 
 engineer specific nanostructures for antigen templating\, allowing us to c
 ontrol the valency of IgG. These DNA nano-templated IgG complexes were abl
 e to activate complement on cell-mimetic lipid membranes\, offering valuab
 le insights into the impact of IgG valency on complement activation withou
 t the need to mutate the antibodies. We employed biophysical assays in con
 junction with 3D cryo-electron tomography to investigate this phenomenon f
 urther. Our findings show that the cleavage of complement component C4 by 
 the C1 complex is proportional to the number of antigens present. Addition
 ally\, higher IgG valency correlated with improved activation of the termi
 nal complement pathway and the formation of the membrane attack complex. T
 hese results demonstrate how nanopatterning antigen-antibody complexes inf
 luence C1 complex activation\, suggesting potential routes for modulating 
 complement activation through antibody engineering.In a parallel line of r
 esearch\, we explored the unique characteristics of IgG3 antibodies. IgG3 
 stands out among IgG subclasses due to its extended hinge region\, allotyp
 ic diversity\, and superior effector functions\, such as highly efficient 
 pathogen neutralization and complement activation. Despite its potential\,
  IgG3 has been underrepresented as an immunotherapeutic candidate\, primar
 ily due to a lack of structural information. To bridge this knowledge gap\
 , we use cryoEM to determine the structures of antigen-bound IgG3\, both i
 n isolation and in complex with complement components. These structural an
 alyses unveiled a tendency for IgG3-Fab clustering\, facilitated by the fl
 exible upper hinge region specific to IgG3\, potentially maximizing pathog
 en neutralization through high-density antibody arrays. IgG3 also forms el
 evated hexameric Fc platforms that extend above the protein corona\, enhan
 cing receptor binding and interactions with the complement C1 complex\, wh
 ich displayed a unique protease conformation in this context\, possibly pr
 eceding C1 activation. Mass spectrometry results indicated that C1 deposit
 s C4b directly onto specific IgG3 residues in proximity to the Fab domains
 . This is attributed to the height of the C1-IgG3 complex. This knowledge 
 is valuable for the development and design of future immunotherapeutics ba
 sed on IgG3\, potentially expanding its role in therapeutic applications.
LOCATION:Sunstone Building - Big Seminar Room B \, ISTA
ORGANIZER:
SUMMARY:Leoni Abendstein: Structural insights into the activation of the cl
 assical complement system 
URL:https://talks-calendar.ista.ac.at/events/4588
END:VEVENT
END:VCALENDAR
